Neuronetics (STIM) Cost of Revenue (2017 - 2026)

Neuronetics (STIM) has 10 years of Cost of Revenue data on file, last reported at $18.3 million in Q1 2026.

• On a quarterly basis, Cost of Revenue rose 12.71% year-over-year to $18.3 million in Q1 2026; TTM through Mar 2026 was $78.9 million, a 141.79% increase from a year earlier, with the FY2025 full-year figure at $76.8 million, up 270.73% from the prior year.
• Cost of Revenue for Q1 2026 stood at $18.3 million, down from $20.1 million in the prior quarter.
• Over the last five years, Cost of Revenue for STIM reached as high as $20.3 million in Q2 2025 and fell as low as $3.5 million in Q1 2022.
• Historically, Cost of Revenue has averaged $8.9 million across 5 years, with a median of $4.5 million in 2023.
• Across the five-year window, Cost of Revenue dropped 26.0% in 2024 and surged 376.47% in 2025, its largest moves.
• Year by year, Cost of Revenue stood at $4.4 million in 2022, then grew by 3.49% to $4.5 million in 2023, then surged by 67.29% to $7.6 million in 2024, then surged by 164.12% to $20.1 million in 2025, then fell by 8.83% to $18.3 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $18.3 million in Q1 2026, $20.1 million in Q4 2025, and $20.2 million in Q3 2025.